Results 21 to 30 of about 69,866 (217)

Most bothersome symptom in migraine and probable migraine: A population-based study.

open access: yesPLoS ONE, 2023
Recently, the most bothersome symptom has been recommended as a co-primary endpoint in clinical trials on the acute treatment of migraine. Probable migraine is a subtype of migraine that fulfills all but one criterion for migraine diagnosis.
Seung Jae Kim   +5 more
doaj   +1 more source

Investigation of anxiety, depression and quality of life levels in migraine patients seeking surgical treatment [PDF]

open access: yesKlinik Psikiyatri Dergisi, 2019
Objective: Pharmacotherapeutics have been used as a primary agent in migraine treatment. The detection of triggers that exacerbated migraine in recent years and the effectiveness of the surgical interventions applied in this area have been ...
Murat Yagmur   +3 more
doaj   +1 more source

Memory and Resting‐State Connectivity in Acute Transient Global Amnesia: A Case–Control fMRI Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Transient global amnesia (TGA) is a striking model of isolated amnesia. While hippocampal lesions are well described, the network‐level mechanisms and the precise neuropsychological profile remain debated. Our objective was thus to characterize functional and neuropsychological correlates of acute TGA and their ...
Elias El Otmani   +10 more
wiley   +1 more source

Clinical, demographic, and lifestyle characteristics of patients with cervicogenic headache: comparison with an age- and sex-matched group of individuals with migraine

open access: yesThe Journal of Headache and Pain
Background Cervicogenic headache (CEH) can be frequently misdiagnosed as migraine. This study aimed to compare clinical, demographic, and lifestyle characteristics of patients with CEH and individuals with migraine.
Magdalena Nowaczewska   +4 more
doaj   +1 more source

Preventive treatment response associated with migraine aura subtypes in a Thai population

open access: yesFrontiers in Human Neuroscience, 2023
IntroductionSome studies indicate a different response to treatment between migraine patients with and without aura.ObjectivesTo determine whether aura, or simple or complex aura subtypes, are clinical markers predicting response to preventive treatment ...
Thanin Asawavichienjinda   +1 more
doaj   +1 more source

Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.
Christine Lebrun‐Frenay   +13 more
wiley   +1 more source

Treatment of Medical Therapy-Resistant Vestibular Migraine with Cranial Osteopathy: A Case Report

open access: yesInternational Journal of Traditional and Complementary Medicine Research, 2021
Vestibular migraine is a variant of migraine with episodic vestibular symptoms. Diagnostic criteria were determined in 2012 and the term vestibular migraine was used. Lifetime prevalence in adults is calculated as 1%.
Yaser Said Cetin, Seyhmus Kaplan
doaj  

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau   +11 more
wiley   +1 more source

Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies

open access: yesBrain and Behavior, 2022
Background Current German and European guidelines suggest migraine patients undertake a treatment break after 9 to 12 months of treatment with CGRP (pathway) monoclonal antibodies.
Michael Nsaka   +6 more
doaj   +1 more source

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy